Slowly but surely we are learning more about the roles of family history and familial genetics (heredity) in determining risk for prostate cancer — and most especially risk for clinically significant forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: family, germline, heredity, history, mutation, risk | 3 Comments »
A presentation at the ongoing annual meeting of the European Association of Urology (EAU), in London, England, has reported (perhaps unsurprisingly) that PSA testing for risk of prostate cancer based on family history alone is not a very good idea. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, family, history, PSA, risk, testing | 1 Comment »
We know that a family history of prostate cancer and the presence of certain genetic/genomic markers are associated with increased risk for prostate cancer in general and for some types of clinically significant prostate cancer in particular. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: counseling, family, genetic, history, PSA, risk, score, testing | 3 Comments »
We have known for years that if your father or your brother is diagnosed with prostate cancer, it affects your own risk for prostate cancer … but what sorts of prostate cancer are we talking about? Aggressive, indolent, metastatic, localized, what? … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Diagnosis, family, history, risk | 3 Comments »
In what we believe to be the first report of its kind from anywhere in the world, a new paper has reported that there seems to be no evidence that selective screening of men with a family history of prostate cancer is clinically beneficial compared to men with no family history of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: benefit, family, history, outcome, screening | 1 Comment »
A new paper published on line in the Journal of Urology suggests that the PSA and %free PSA levels of current smokers and former smokers may be statistically significantly impacted compared to those of men who have very rarely or never smoked. …
Filed under: Diagnosis, Risk | Tagged: free, history, PSA, smoking, total | 2 Comments »
The addition of androgen deprivation therapy (ADT) to radiation therapy for men with localized prostate cancer is common. It may be used to reduce the size of the prostate prior to brachytherapy or for longer periods in men with higher risk disease to extend survival (which has been demonstrated in large-scale, randomized, multi-center clinical trials). … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ADT, androgen deprivation therapy, brachytherapy, cardiovascular disease, history, mortality, radiation, risk | 4 Comments »
Additional prostate cancer news this weekend includes the following items:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: BMI, brachytherapy, cancer, factors, familyt, Gleason, hereditary, history, mortality, news update, obesity, outcome, prostate, prostatectomy, PSA, radical, risk, stage, T1a, TURP, velocity | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 